Table 4.
Descriptive statistics by treatment group
| Variable | Methoxyflurane (n = 483) |
Entonox® (n = 753) |
Morphine IV (n = 802) |
Paracetamol IV (n = 278) |
|
|---|---|---|---|---|---|
| Sex | Female | 64.8% | 55.9% | 58.6% | 57.5% |
| Male | 35.2% | 44.1% | 41.4% | 42.5% | |
| Age |
Mean (std dev; range) |
63.1 (22.9; 16–98) |
55.9 (22.1; 18–96) |
61.4 (22.6; 18–99) |
66.6 (20.3; 18–100) |
| GCS | 14 or 15 | 98.1% | 100% | 100% | 100% |
| 13 or lower | 0.4% | - | - | - | |
| Other | 1.5% | - | - | - | |
| Trauma | |||||
| #1 Limb injury or fall ± soft tissue injury | 45.8% | 23.4% | 44.6% | 36.9% | |
| #2 Suspected neck of femur (trauma) or hip injury ± limb or soft tissue injury | 22.4% | 10.4% | 11.8% | 21.5% | |
| #3 Head, neck or back injury ± soft tissue injury | 17.2% | 27.3% | 27.0% | 13.2% | |
| #4 Multisystem or multiple trauma, assault, stab wound, gunshot injury, penetrating trauma | 6.4% | 27.0% | 10.4% | 15.4% | |
| #5 Abdominal or chest injury ± soft tissue injury | 3.1% | 10.8% | 1.7% | 9.1% | |
| #6 Soft tissue or thermal injury | 3.1% | 1.1% | 4.5% | 4.0% | |
| #7 Other | 2.1% | - | - | - | |